Depending on your politics, the $800 billion stimulus was a rousing success or a crushing failure. Neither is accurate.
Like most things in the political world, the truth is somewhere in the middle. For a balanced look at what the Recovery Act has done for the economy, check out ProPublica’s “Eye on the Stimulus” series.
“Automakers have unveiled a number of mass-market electric cars, which have seen small but rising sales,” writes author Michael Grabell. “Battery and parts manufacturers are building 30 factories, creating thousands of new jobs…If it wasn’t for the stimulus, the companies say, they would have built these plants overseas.”
ProPublica is an independent, non-profit newsroom that won Pulitizer Prizes for its reporting in 2010 and 2011.
Dozens of East Tennessee doctors have received millions of dollars in fees from major drug companies in recent years, according to an updated report by the ProPublica public interest website.
Some East Tennessee doctors each were paid $50,000 to $100,000 by AstraZeneca, Cephalon, Eli Lilly, Pfizer and other pharmaceutical companies, according to the “Dollars for Docs” update published Wednesday. A total of more than $20 million went to doctors throughout Tennessee from 2009 to 2011.
Payments include speaking and consulting fees, research, travel and meal costs.
ProPublica columnist Jesse Eisinger offers a withering take on Goldman Sachs’ promise last week to behave better and be more open about its business dealings.
In a nutshell, Eisinger finds the 63-page Business Standards Committee Report a public relations stunt.
” … Some of it was welcome, like the increased financial disclosure. Some may fall by the wayside, like most New Year’s resolutions. Some seems as disingenuous as any piece of professional flackery,” Eisinger writes.
“And true to life, the game is driven by profit–first player to make $120 million wins. But watch out for those “hazard cards,” one of which states : “Blow-out! Rig damaged. Oil slick clean-up costs. Pay $1million,” ProPublica reports.